Minnesota

Disorders Screened in Minnesota
Minnesota requires comprehensive newborn screening for 53 disorders per national recommendations as determined by the American College of Medical Genetics (ACMG). Diseases and conditions apparent through screening will be reported even if they are not included in the required screening.

The disorders that are required to be screened by your state's program are identified by the National Newborn Screening and Genetics Resource Center in simplified format or in PDF format.

If you have trouble with the PDF file, then
Download the FREE version of Adobe Reader.

General Information
Minnesota babies are screened through a partnership between the Minnesota Department of Health and the Mayo Clinic. Each partner screens for particular disorders and collaborates closely in interacting with families, providers, and specialty centers. The state added cystic fibrosis screening to its panel on March 1, 2006, thereby meeting national recommendations per the American College of Medical Genetics (ACMG) for blood-spot screening.

Background: Legislation passed in June, 2003, enhanced the Minnesota Department of Health Newborn Screening Program, authorized a newborn screening fee of $61, and provided additional data privacy for families. Benefits of the legislation included developing a partnership with the Mayo Clinic to sustain and expand the use of tandem mass spectrometry (MS/MS); lowering the number of false positives for congenital adrenal hyperplasia; reducing the turn-around time for laboratory results; enhancing education for parents and providers; and increasing support for coordinated care of identified families.

Since June, 2001, the Minnesota Department of Health has screened all babies for analytes related to metabolic disorders detectable by MS/MS.  When presumptive positive cases are identified, the primary care provider and appropriate medical specialist are contacted to ensure that the infant is cared for in an effective, clinically appropriate manner.

The Minnesota Department of Health received the assistance of local clinicians throughout the newborn screening implementation process.  Contributors have included individuals at Fairview University , Mayo Clinic and Mayo Medical Laboratory's Biochemical Genetics Laboratory.

Newborn Screening Advisory Committee
The Minnesota Newborn Screening Advisory Committee (NBSAC) is comprised of parents with affected children, primary care providers, clinicians and researchers specializing in newborn diseases and disorders, geneticists, birth hospital representatives, newborn screening lab professionals, nutritionists, and other experts as needed.

Minnesota NBSAC Chairperson
Mr. Steven Johnson, parent of an affected child

Contact Information for the NBSAC
Mr. Mark McCann
Newborn Screening Program Supervisor
Public Health Laboratory Division
Minnesota Department of Health
601 N. Robert Street
P.O. Box 64899
Saint Paul, MN 55164-0899
Ph: 651-201-5450

NBSAC Meeting Dates
The NBSAC meets semi-annually.

Location of Meetings
Saint Paul, MN

• Minnesota Family Village Community Center
• Minnesota Newborn Screening Program Website